{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:11:13Z","timestamp":1759590673183,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Centre for Training in Clinical Cerebrovascular and Cardiovascular Research"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.clineuro.2011.12.023","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T04:58:16Z","timestamp":1325825896000},"page":"613-616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systemic arterial inflammation, measured with 18FDG-PET, is common amongst subjects with both recent and prior cerebrovascular disease"],"prefix":"10.1016","volume":"114","author":[{"given":"Christopher D.","family":"Beer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nat","family":"Lenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Blacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard F.","family":"Arnolda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme J.","family":"Hankey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian B.","family":"Puddey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clineuro.2011.12.023_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2377-4-2","article-title":"Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome","volume":"4","author":"Smith","year":"2004","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.clineuro.2011.12.023_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000077012","article-title":"Progression in lacunar stroke is related to elevated acute phase parameters","volume":"51","author":"Audebert","year":"2004","journal-title":"Eur Neurol"},{"issue":"5","key":"10.1016\/j.clineuro.2011.12.023_bib0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.clineuro.2007.02.012","article-title":"Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography: pilot study","volume":"109","author":"Arauz","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"10.1016\/j.clineuro.2011.12.023_bib0020","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1161\/STROKEAHA.107.504753","article-title":"Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal stenosis","volume":"39","author":"Tang","year":"2008","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.clineuro.2011.12.023_bib0025","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1161\/01.STR.0000190896.67743.b1","article-title":"Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging","volume":"36","author":"Davies","year":"2005","journal-title":"Stroke"},{"issue":"23","key":"10.1016\/j.clineuro.2011.12.023_bib0030","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/01.CIR.0000020548.60110.76","article-title":"Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography","volume":"105","author":"Rudd","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.clineuro.2011.12.023_bib0035","first-page":"608","article-title":"Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET\/CT examinations","volume":"46","author":"Brix","year":"2005","journal-title":"J Nucl Med"},{"issue":"8756","key":"10.1016\/j.clineuro.2011.12.023_bib0040","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0140-6736(91)93206-O","article-title":"Classification and natural history of clinically identifiable subtypes of cerebral infarction","volume":"337","author":"Bamford","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clineuro.2011.12.023_bib0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1747-4949.2007.00111.x","article-title":"VITATOPS, the vitamins to prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444)","volume":"2","year":"2007","journal-title":"Int J Stroke"},{"issue":"3","key":"10.1016\/j.clineuro.2011.12.023_bib0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000199463","article-title":"Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial","volume":"27","author":"Potter","year":"2009","journal-title":"Cerebrovasc Dis"},{"issue":"9479","key":"10.1016\/j.clineuro.2011.12.023_bib0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)66702-5","article-title":"A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack","volume":"366","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clineuro.2011.12.023_bib0060","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","article-title":"In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients","volume":"48","author":"Tawakol","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.clineuro.2011.12.023_bib0065","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jacc.2007.05.024","article-title":"(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials","volume":"50","author":"Rudd","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.clineuro.2011.12.023_bib0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12350-011-9338-3","article-title":"Uptake of 18F-FDG and ultrasound analysis of carotid plaque","volume":"18","author":"Choi","year":"2011","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1016\/j.clineuro.2011.12.023_bib0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.atherosclerosis.2006.07.019","article-title":"Imaging of vulnerable atherosclerotic plaques with FDG-microPET: no FDG accumulation","volume":"192","author":"Laurberg","year":"2007","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.clineuro.2011.12.023_bib0080","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.atherosclerosis.2006.10.027","article-title":"Response to \u2018Laurberg JM, Olsen AK, Hansen SB, et al. Imaging of vulnerable atherosclerotic plaques with FDG-microPET: no FDG accumulation\u2019 [Atherosclerosis 2006]","volume":"192","author":"Rudd","year":"2007","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.clineuro.2011.12.023_bib0085","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3174\/ajnr.A2381","article-title":"Potential of integrated [18F] fluorodeoxyglucose positron-emission tomography\/CT in identifying vulnerable carotid plaques","volume":"32","author":"Kwee","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"10.1016\/j.clineuro.2011.12.023_bib0090","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2967\/jnumed.107.050294","article-title":"Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations","volume":"49","author":"Rudd","year":"2008","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.clineuro.2011.12.023_bib0095","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/STROKEAHA.108.521393","article-title":"Comparison of methods for magnetic resonance-guided [18F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods","volume":"40","author":"Izquierdo-Garcia","year":"2009","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.clineuro.2011.12.023_bib0100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2967\/jnumed.109.065698","article-title":"Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques","volume":"51","author":"Sch\u00e4fers","year":"2010","journal-title":"J Nucl Med"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384671100432X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384671100432X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:30:00Z","timestamp":1759588200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030384671100432X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S030384671100432X"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2011.12.023","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic arterial inflammation, measured with 18FDG-PET, is common amongst subjects with both recent and prior cerebrovascular disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2011.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}